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Abstract 14 
The aim of this study was to demonstrate how seasonal variability in the removal efficacy of 15 
enteric viral pathogens from an MBR-based water recycling system might affect risks to 16 
human health if the treated product were to be used for the augmentation of potable water 17 
supplies. Samples were taken over a twelve month period (March 2014- February 2015), 18 
from nine locations throughout a water recycling plant  situated in East London and tested for 19 
faecal indicator bacteria (thermotolerant coliforms , intestinal enterococci  n=108), phages 20 
(somatic coliphage , F-specific RNA phage and Bacteroides phage (GB-124) n=108), 21 
pathogenic viruses (adenovirus , hepatitis A , norovirus GI/GII  n=48) and a range of 22 
physico-chemical parameters (suspended solids, DO, BOD, COD). Thermotolerant coliforms 23 
and intestinal enterococci were removed effectively by the water recycling plant throughout 24 
the study period. Significant mean log reductions of 3.9-5.6 were also observed for all three 25 
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phage groups monitored. Concentrations of bacteria and phages did not vary significantly 26 
according to season (P<0.05; Kruskal-Wallis), though recorded levels of norovirus (GI) were 27 
significantly higher during autumn/winter months (P=0.027; Kruskal-Wallis). Log reduction 28 
values for norovirus and adenovirus following MBR treatment were 2.3 and 4.4, respectively. 29 
However, both adenovirus and norovirus were detected at low levels (2000 and 3240 gene 30 
copies/L, respectively) post chlorination in single samples. Whilst phage concentrations did 31 
correlate with viral pathogens, the results of this study suggest that phages may not be 32 
suitable surrogates, as viral pathogen concentrations varied to a greater degree seasonally 33 
than did the phage indicators and were detected on a number of occasions on which phages 34 
were not detected (false negative sample results). 35 
Keywords 36 
Bacteriophages; Health; Pathogenic virus; Removal efficacy; Wastewater reuse  37 
 38 
1. Introduction 39 
Treated wastewater is increasingly recognised to be a valuable and sustainable resource, 40 
particularly as greater affluence, population growth and climate change are projected to 41 
increase the demand on limited conventional freshwater supplies. Reuse of treated 42 
wastewaters is already used to supplement water supplies for non-potable uses in many parts 43 
of the world and the practice has the potential to provide potable water as long as the risks to 44 
human health associated with the consumption of wastewater contaminants, including 45 
pathogenic microorganisms, are comprehensively and continuously controlled. Currently, 46 
there is no consensus as to what standards are appropriate to govern wastewater reuse 47 
(Paranychianakis et al., 2015). However, to date the most stringent regulations have been 48 
issued in the United States (US) by the California Department of Public Health (2014), which 49 
relate to indirect reuse of wastewaters as a source of raw drinking water through groundwater 50 
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recharge. These regulations require a 12 log reduction in enteric virus concentrations, a 10 51 
log Giardia cyst reduction and a 10 log Cryptosporidium oocyst reduction.  52 
 53 
Membrane bioreactor (MBR) technology has been proposed as being highly suitable for 54 
water reuse (Hai et al., 2014). A membrane bioreactor is a treatment process that achieves 55 
separation of solids by combining a permselective membrane with a biological process (Judd, 56 
2011, De Luca et al., 2013). Solids are therefore removed by the membrane, rather than a 57 
secondary settling process. Membranes have relatively small pore sizes (0.03 - 0.40 µm), 58 
resulting in the physical exclusion of a wide variety of microorganisms (Ottoson et al., 2006; 59 
Simmons et al., 2011). The majority of viruses are smaller than the membrane pore sizes 60 
present in MBR treatment systems. Nevertheless studies have reported virus removal, as 61 
reviewed by (Hai et al 2014). Studies, performed at both pilot-scale and within full-scale 62 
municipal wastewater plants, have demonstrated that microbial removal in MBR systems is 63 
more effective than in conventional activated sludge treatment systems (Ottoson et al., 2006; 64 
Marti et al., 2011). 65 
 66 
There is some disagreement as to the most important mechanisms for virus removal in MBR. 67 
Although removal is thought to be primarily influenced by the development of a biofilm on 68 
the membrane, and by virus adsorption to this biomass (Da Silva et al., 2007; Wong et al., 69 
2009; Hirani et al., 2014; van den Akker et al., 2014), recent research has reported that virus 70 
removal is ensured by a smaller membrane pore size (0.04 µm), even after chemically-71 
enhanced membrane backwashes (Chaudhry et al., 2015). In contrast, Miura et al. (2015) 72 
found that virus adsorption to mixed-liquor suspended solids (MLSS) made an important 73 
contribution to virus removal in a pilot-scale ‘anoxic-oxic’ (AO) MBR process with a 74 
nominal membrane pore size of 0.4 µm.  75 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
 76 
Other workers have monitored pathogenic viruses in MBR directly using quantitative 77 
polymerase chain reaction (qPCR) methodologies, which are based on the detection of 78 
nucleic acids, rather than of complete, infectious particles (virions). In a range of studies, 79 
MBR treatment systems have recorded log reductions of between 3.9 and 5.5 log units for 80 
adenovirus (Adv), 1.3 and 4.1 log units for sapovirus (SaV), 0.2 and 5.7 log units for 81 
norovirus genogroup II (NoV GII), 0.3 and 3.6 log units for enterovirus (EnV), and 3.3 and 82 
6.8 log units for calcivirus (CaV) (Chaudhry et al., 2015; Kuo et al., 2010; Miura et al., 2015; 83 
Ottoson et al., 2006; Sima et al., 2011; Simmons et al., 2011). Whilst qPCR allows for the 84 
detection of unculturable pathogens, such as NoV GI/II, the detection of nucleic acids from 85 
damaged particles in treated product, may lead to over-estimates of the risk to human health 86 
of reuse water. The method also remains prohibitively expensive as a means to  monitor 87 
routinely the wide range of pathogens of public health concern that may be present in waters 88 
and wastewaters, as a component of regulatory practise. Therefore, the enumeration of 89 
viruses capable of infecting bacteria (bacteriophages or phages) has been proposed as a way 90 
to model the removal of enteric viruses in treatment systems (IAWPRC, 1991).  91 
 92 
In numerous studies, phages have been shown to be the most suitable available indicator of 93 
the presence of enteric viruses in water and wastewaters (Jofre et al., 1986; Gantzer et al., 94 
1998; Purnell et al., 2011; Ebdon et al., 2012; Jofre et al., 2014), because they have a similar 95 
structure, morphology, size and resistance to inactivation to the viral pathogens of concern. 96 
Membrane bioreactor systems with varying nominal pore sizes (0.04-0.4 µm), have been 97 
shown to remove up to 7.1 log units of various indigenous and artificially introduced ‘spiked’ 98 
phages (Chaudhry et al., 2015; Hirani et al., 2012; Marti et al., 2011; Ueda and Horan, 2000; 99 
Wong et al., 2009; Zanetti et al., 2010; Zhang et al., 2007). The lowest log removal values 100 
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were most frequently attributed to ‘spiked’ phages with clean membranes, rather than 101 
indigenous phages that were more likely to be associated with solids (Shang et al., 2005). 102 
Purnell et al. (2015) studied the removal of somatic coliphages (SC), F-specific RNA (F-103 
RNA) phages and Bacteroides fragilis (GB-124) phages through a full-scale MBR system 104 
with submerged aerated ultra-filtration membranes (nominal pore size of 0.04 µm) and 105 
posited that SC may represent a potential conservative model by which to assess the efficacy 106 
of viral pathogen removal in MBR systems, although they did not elucidate the relationships 107 
between candidate phages and specific enteric viral pathogens of public health significance.  108 
 109 
Globally, as freshwater resources become more stressed, wastewater reuse is increasingly 110 
considered to be an acceptable way to provide non-potable and more recently to augment 111 
potable water supplies. However, the primary concern of wastewater reuse is to ensure that 112 
the potential public health consequences are properly understood and effectively minimized. 113 
Unfortunately, the lack of uniform water quality guidelines and uncertainties about the 114 
removal efficacy of the available wastewater reuse technologies has adversely affected the 115 
development, public perception, and economic viability of wastewater reuse projects. 116 
Membrane bioreactor technology (MBR) has the potential to provide treated wastewater of a 117 
sufficient quality to augment potable water supplies, but knowledge gaps with regard to the 118 
removal of viruses in MBR and the relationship between pathogenic viruses and their 119 
potential surrogates remain. This has meant that the full potential of such MBR technologies 120 
to treat wastewater for different reuse purposes is only now beginning to be recognised. In 121 
addition, whilst research has shown encouragingly high removal values for viruses, studies of 122 
full-scale MBR’s remain limited (da Silva et al., 2007; Kuo et al., 2010; 2011; Chaudry et al., 123 
2015), and to date, no full-scale study has investigated the removal of potential viral 124 
surrogates and pathogenic viruses over the course of an entire year.  125 
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 126 
In light of this, the aim of this study was to demonstrate how seasonal variability in the 127 
removal efficacy of enteric viral pathogens from an MBR-based water recycling system 128 
might affect risks to human health if the treated product were to be used for the augmentation 129 
of potable water supplies. This was achieved by; a) monitoring the virus removal efficacy of 130 
a full-scale MBR treatment system over an entire year (using traditional faecal indicators, 131 
enteric phages, and viral pathogens), b) identifying seasonal fluctuations in system 132 
performance over this period and c) assessing whether enteric phages may be used as 133 
surrogates for the presence of enteric viral pathogens, which could in turn inform future 134 
monitoring and regulation practises.  135 
 136 
2. Materials and methods 137 
2.1 The membrane bioreactor water recycling plant 138 
The Old Ford Water Recycling Plant (WRP) in London, UK, treats raw municipal 139 
wastewater, taken from the Northern Outfall Sewer, to provide 574 m3 of  non-potable water 140 
per day to the Queen Elizabeth Olympic Park for the purposes of parkland irrigation, venue 141 
toilet flushing and to supplement rain water harvesting systems (Hill and James, 2014). The 142 
raw wastewater is predominantly domestic and light commercial in origin with additional 143 
surface drainage inputs from a relatively large catchment that has a population of 144 
approximately 360,000. The Old Ford WRP receives a relatively small proportion of the flow 145 
from the Northern Outfall Sewer. The series of unit processes that constitutes full treatment 146 
of the wastewater are summarised in Figure 1. The processes comprise a pre-treatment stage 147 
with gross solids removal using underground septic tanks (hydraulic retention time (HRT) 148 
6.46 hrs) followed by 1 mm fine screens to remove large debris (hair and fibres that could 149 
potentially damage the membrane). Screened wastewater flows to an above-ground activated 150 
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sludge tank (that operates at a mixed-liquor suspended solids concentration of 7 g/L), which 151 
is segregated into anoxic (HRT 0.52 hrs) and aerobic zones (HRT 2.50 hrs). The wastewater 152 
then flows to a cross-flow membrane tank that holds three racks of ultra-filtration membranes 153 
(with a nominal pore size of 0.04 µm and a HRT of 0.18 hrs (Siemens Water Technologies 154 
Memcor Ltd)), which have pulsated air scouring to mitigate membrane fouling and are 155 
periodically cleaned in place (1500mg/l of hypochlorite for 6-8 hrs every 90 days). In 156 
addition, maintenance washes are performed every seven days (300 mg/l of hypochlorite for 157 
45 minutes). The reclaimed wastewater undergoes post-treatment in the form of granular 158 
activated carbon (GAC), primarily for colour removal (HRT 0.58 hrs) and chlorination (0.3 to 159 
1.5 mg/l chlorine residual, contact time 0.51 hrs) before entering a dedicated 3.65 km 160 
distribution network. 161 
 162 
2.2 Monitoring programme 163 
Levels of a selection of faecal indicator organisms (thermotolerant coliforms (TTC), 164 
intestinal enterococci (IE), somatic coliphage (SC), F-specific RNA phages (F-RNA) and 165 
phages infecting Bacteroides fragilis strain (GB124)) and enteric viral pathogens of public 166 
health concern (norovirus GI & GII (NoV), adenovirus (AdV), and hepatitis A virus (HAV) 167 
were monitored at multiple points in the WRP. Figure 1 shows the nine sampling points (1-168 
9), at which phages and faecal indicator bacteria were monitored and the four sampling points 169 
(a-d) at which viral pathogens were monitored. The lower number of sampling points for 170 
viral pathogens was a practical response to the large volumes of sample (10L) that were 171 
required for their enumeration. All samples were transported to the University of Brighton 172 
laboratory, in the dark, at 4oC, for analysis within four hours of collection. 173 
 174 
2.3 Quantification of faecal indicator organisms 175 
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TTC and IE were enumerated by membrane filtration on mFC agar, and MEnterococcus agar 176 
(Difco), respectively, in triplicate, according to standard methods (Anon., 2000) and 177 
expressed as colony-forming units per 100 ml (CFU/100 ml). SC, F-RNA and GB124 phages 178 
were quantified by enumerating plaque-forming units (PFU/100ml), in triplicate, on Modified 179 
Scholten’s Media, Tryptone Yeast Glucose Media and Bacteroides Phage Recovery Media, 180 
respectively, according to standardised double-agar-layer methods (Anon, 2001[a-c]). Host 181 
strain WG5 was used for SC enumeration, Salmonella typhimurium WG49 was used for F-182 
RNA enumeration, and Bacteroides fragilis was used for GB124 phage enumeration. 183 
 184 
2.4 Concentration of samples for detection of pathogenic viruses  185 
Samples were concentrated using a skimmed milk flocculation procedure, as described 186 
previously by Calgua et al. (2013). Before concentration, the conductivities of all samples 187 
were measured, and all those with a conductivity ≤1.5mS were conditioned by adding 188 
artificial sea salts (Sigma-Aldrich, UK) to obtain values ≥1.5mS. Once samples were 189 
conditioned, a pre-flocculated 1 % (w/v) skimmed milk solution (PSM) was prepared by 190 
dissolving 10 g skimmed milk powder (Difco, USA) into 1L of artificial sea water at a pH of 191 
3.5. The pH of the sample was reduced to 3.5 by adding HCL 1N. Then, PSM was added to 192 
achieve a final concentration of 0.01 % (w/v) skimmed milk in each sample. Samples were 193 
stirred for 8 h at room temperature using a magnetic stirrer (Grant, UK) and flocs were 194 
allowed to form and to sediment by gravity for an additional 8-10 hrs. The supernatant was 195 
removed with care, so as not to disturb the sedimented floc. The final volume of 500 ml, 196 
including the sedimented floc was transferred to centrifuge tube(s) and centrifuged at 7000 x 197 
g for 30 min at 4oC. The supernatant was carefully removed and the pellet was re-suspended 198 
and dissolved in phosphate buffer (1:2, v/v of Na2HPO4 0.2 M and NaH2PO4 0.2M) at pH 199 
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7.5, at a ratio of 1 ml of phosphate buffer per 1 L of concentrated sample. The resulting viral 200 
concentrate was then stored at -80oC. 201 
 202 
2.5       Nucleic acid extractions 203 
Nucleic acid extractions (DNA and RNA) were performed using the QIAamp Fast DNA stool 204 
Mini Kit and the QIAamp Viral RNA Mini Kit (Qiagen, USA), respectively, according to the 205 
manufacturer’s instructions. For DNA, 220 µl of concentrated sample were extracted and 206 
eluted in 200 µl of elution buffer. For RNA, 140 µl of concentrated sample were extracted 207 
and eluted in 60 µl of elution buffer. Nucleic acids were stored at -80oC until further analysis. 208 
Following extraction, the quantities of viral nucleic acid extracts from all samples were 209 
checked using a NanoDrop Lite Spectrophotometer (NanoDrop Lite®, Labtech, UK).   210 
 211 
2.6 Quantitative real-time PCR assays 212 
All qPCR assays were performed using a Qiagen Rotor-gene Q. ‘Positive’, ‘no template’ and 213 
‘internal extraction’ controls were used in every assay run. Dilutions were used to decrease 214 
inhibition in samples. Genesig kits were used for the detection of AdV type F and G, NoV 215 
GI/II genomes and HAV virus genomes (PrimerDesign™, UK). The target sequence (hexon 216 
gene) has previously been shown to be a good genetic marker for AdV in other real-time 217 
PCR-based studies (Hernroth et al., 2002). The primers present 100% homology with all 218 
reference sequences included in the NCBI database (as of 1st November 2007) and therefore 219 
these kits are considered to have very broad detection profiles. For AdV, each sample (5 µl) 220 
was prepared with a 15 µl reaction mix, containing 10 µl PrecisionPLUSTM 2 x qPCR 221 
MasterMix, 1 µl primer/probe mix, 1 µl internal extraction control primer/probe mix and 3 µl 222 
RNAse/DNAse free water. For both NoV GI/II and HAV detection, each sample (5 µl) was 223 
prepared with a 15 µl reaction mix, containing 10 µl PrecisionTM OneStep 2 x qRT-PCR 224 
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MasterMix, 1 µl primer/probe mix, 1 µl internal extraction control primer/probe mix and 3 µl 225 
RNAse/DNAse free water. Thermal conditions for AdV consisted of enzyme activation for 2 226 
minutes at 95 oC, followed by 50 cycles of denaturation for 10 seconds at 95 oC and data 227 
collection for 60 seconds at 60 oC. NoV and HAV detection followed the same thermal 228 
conditions, with the addition of a reverse transcription stage of 10 minutes at 42 oC before 229 
enzyme activation. Results were expressed as log gene copies per 1 L.  230 
 231 
2.7 Log removal values 232 
 Log removal values (LRV) for microbial parameters were calculated for the three treatment 233 
stages shown in Figure 1, according to equation (1). Where Cinitial is the starting concentration 234 
of microorganisms, and Cfinal is the concentration of microorganisms after the treatment stage 235 
of interest.  236 
 237 
LRV = -log10 (Cinitial / Cfinal)                      (1) 238 
 239 
3. Results and discussion  240 
3.1   Faecal indicator bacteria 241 
Mean log levels of TTC and IE recorded at the nine sampling points through the Old Ford 242 
WRP are presented in Figure 2. Mean numbers following MBR treatment were reduced to <1 243 
CFU/100 ml for both IE and TTC. Following chlorination, both IE and TTC were undetected 244 
(<1 CFU/100ml) in all samples. Mean removal values following the MBR stage were 7.0 log 245 
and 6.2 log for TTC and IE, respectively. Concentrations of faecal indicator bacteria 246 
throughout the treatment stages did not vary significantly according to season (P<0.05; 247 
Kruskal-Wallis).   248 
 249 
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3.2   Phages 250 
The mean log number of the three phage groups somatic coliphages (SC), F-specific RNA 251 
phages (F-RNA); and Bacteroides GB124 phage (GB124), detected at each stage of the Old 252 
Ford WRP system are shown in Figure 3. Of the three bacteriophages monitored, SC were 253 
shown to be present at the highest concentrations throughout the system, with levels as high 254 
as 2.5 x 106 PFU/100ml recorded in the raw wastewater. Significant mean reductions in SC 255 
numbers were observed following MBR treatment (5.6 log). GB124 and F- RNA phages also 256 
demonstrated notable reductions following MBR treatment, with mean reductions of 4.0 and 257 
3.9 log, respectively. GB124 and F-RNA phages were undetected (<1 PFU/100ml) in all 258 
post-MBR treatment samples. SC were the only group observed in MBR product. This 259 
finding is consistent with a previous study by the same authors (Purnell et al., 2015). The 260 
concentrations of the three phage groups detected at each stage of treatment did not vary 261 
significantly according to season (P<0.05; Kruskal-Wallis). 262 
 263 
The detection of SC in MBR product may possibly be explained by “breakthrough” of viruses 264 
at a threshold concentration. Alternatively, Purnell et al. (2015) determined SC morphology 265 
post-MBR treatment and found only phages belonging to the family Microviridae suggesting 266 
that morphology and attachment characteristics could be the major factors influencing 267 
removal (as SC are a morphologically diverse group of phages compared with F-RNA and 268 
GB124 phages). Surface electrostatic charge affects the adsorptive behaviour of viruses 269 
(Michen and Graule, 2010). Miura et al. (2015) also suggest that the interfacial characteristics 270 
of viruses cause diversity of attachment behaviour to MLSS, resulting in varying removal 271 
properties in an MBR process.  272 
 273 
3.3   Enteric viral pathogens  274 
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Four groups of viral pathogens were monitored: namely, adenovirus (AdV), hepatitis A 275 
(HAV), norovirus genogroup I and norovirus genogroup II (NoV GI/GII). The results for 276 
NoV GI/II (human-associated genogroups) were combined to demonstrate the removal of 277 
NoV as a whole. Figure 4 presents the mean levels of these viral groups at each of the four 278 
selected stages of the Old Ford WRP. Of the enteric viruses monitored, AdV were observed 279 
at the highest concentrations, with levels as high as 1.2 x 108 gene copies/L recorded in the 280 
raw wastewater. NoV GI/GII were detected in raw wastewater at a level of 6.2 x 105 gene 281 
copies/L. Log reduction values post-MBR for NoV and AdV were 2.3 and 4.4, respectively. 282 
It is important to note that both AdV and NoV were detected after the chlorination stage of 283 
the treatment system in single samples (AdV was detected in July, whereas NoV was 284 
detected in February). Conversely HAV was undetected (<2 gene copies/reaction) in all 285 
samples.  286 
 287 
Concentrations of AdV and NoV GI/II fluctuated to a greater degree than those of the enteric 288 
phages monitored. Concentrations of viral pathogens in raw wastewater can vary because 289 
excreted loads change according to the proportion of the population infected with these 290 
viruses at any one time. Interestingly, levels of AdV in the raw wastewater were observed to 291 
increase from autumn through to winter, though this variation was not statistically significant 292 
(P= 0.085; Kruskal-Wallis). In temperate climates, NoV has been shown to be more prevalent 293 
in cooler months (de la Noue, 2014) and in this study NoV GI was detected at higher levels in 294 
autumn and winter months, a seasonal variation that was statistically significant (P=0.027; 295 
Kruskal-Wallis). Whilst levels were not significantly different across the four seasons 296 
(P=0.139; Kruskal-Wallis), recorded levels of NoV GII were highest in the summer months.  297 
 298 
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Recorded log reduction of the enteric viral pathogens was comparable with those of the 299 
enteric phages. However, AdV and NoV were detected in chlorinated product. Pathogenic 300 
viruses were detected using qPCR, a molecular technique that does not distinguish between 301 
viable (potentially infectious) and non-viable (non-infectious/damaged) virus particles. So, 302 
whilst this result does suggest AdV and NoV GI/II passed through the membrane, the data do 303 
not reveal whether these organisms were intact and infectious particles of public health 304 
concern after the chlorination stage. Despite evidence of very occasional viral 305 
“breakthrough”, log reduction values suggested that the system is capable of acting as an 306 
effective physical barrier to the transmission of human viral pathogens. This observation is 307 
also supported by recent research from other similar full-scale systems that have 308 
demonstrated viral pathogen removal rates of greater than 4 log (Chaudhry et al., 2015; Kuo 309 
et al., 2010; Simmons et al., 2011).  310 
 311 
3.4   Enteric bacteriophages as surrogates for viral pathogens 312 
Figures 3 and 4 present mean concentrations for all the studied viral pathogens and enteric 313 
phages throughout the Old Ford WRP.. Levels of all three phage groups were found to 314 
correlate positively with levels of both AdV and NoV GI/II (P<0.05; Spearman’s Rank) when 315 
data from all seasons were analysed together, as shown in Table 1. However, levels of phage 316 
indicators did not correlate with those of NoV genogroups during the winter months or with 317 
AdV during the summer months (P>0.05; Spearmans Rank). The lack of correlation between 318 
phage indicators and NoV GI/II during the winter may be because there is increased 319 
prevalence of NoV in the human community (and consequently its wastewater) at this time of 320 
the year, whereas concentrations of the three phage groups remain relatively stable 321 
throughout the year. Correlation between indicators and AdV is not evident during the 322 
summer months. This may be the result of potential differential inactivation of the phage 323 
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groups and AdV, but further investigation is warranted before definitive conclusions are 324 
drawn. Of the three phage groups, SC demonstrated the strongest positive correlation with 325 
AdV and NoV across all four seasons and the log reductions of the phages did not differ 326 
significantly from those of the viral pathogens (P>0.05, Kruskal-Wallis). A number of 327 
instances of phage detection in samples post-MBR can be considered to be ‘false positive’ 328 
sample results (in terms of using phages as a surrogate for viral pathogens), because phage 329 
groups were detected when viral pathogens were not. More importantly for the protection of 330 
public health, there were also a number of ‘false negative’ sample results, in which viral 331 
pathogens were detected in post-MBR samples but phages were not. For both FRNA and 332 
GB124 phages there were no false positive sample results post-MBR throughout the length of 333 
this study, as these groups were absent in MBR and chlorinated product. However, on the 334 
four occasions viral pathogens on which detected post-MBR treatment, neither phage group 335 
were present (4/4 false negatives sample results). Somatic coliphages were recorded on a 336 
single occasion on which viral pathogens were also detected in MBR product, but again were 337 
absent on the three other occasions on which viral pathogens were detected (three false 338 
negatives sample results). Somatic coliphages were also detected on five occasions on which 339 
viral pathogens were not (five false positives sample results). These results suggest that these 340 
phage groups may not be suitable surrogates of viral pathogens in this type of treatment 341 
system. However, viral pathogens were detected using qPCR, whilst phages were detected 342 
using culture-based methods. Therefore there is some uncertainty as to the 343 
viability/infectivity of these viral pathogen particles. In order to be confident that phages are 344 
suitable surrogates of the viral pathogens monitored in this investigation, it will first be 345 
necessary to establish the infectivity of the virus particles, to ensure that they do indeed pose 346 
a risk to the human health of end users. Therefore future studies should ideally involve a 347 
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blend of cell culture infectivity assays, run in parallel with culture dependant and culture 348 
independent detection of phages and viral pathogens (where possible).  349 
 350 
3.5 Physico-chemical conditions  351 
The physico-chemical conditions at each stage of the Old Ford WRP system are shown in 352 
Table 2. As shown in Table 2, suspended solids, BOD and COD were efficiently reduced by 353 
the MBR treatment system. Statistically significant relationships were observed between 354 
levels of viruses and concentrations of BOD, COD and suspended solids (P=<0.05; 355 
Spearman’s Rank). However, no statistical relationships were observed between the 356 
concentration of mixed-liquor suspended solids and numbers of viral indicators and 357 
pathogens present in the MBR product (P=>0.05; Spearman’s Rank). 358 
 359 
3.6 Contribution of treatment stages to log removal values 360 
Figure 5 presents the percentage contribution of treatment processes (Treatment Stages 1, 2 361 
and 3, illustrated in Figure 1) to viral log removal values at the Old Ford WRP. The results 362 
show that for AdV and NoV the largest percentage contribution to removal was the 363 
membrane itself (Treatment Stage 2), whilst for FRNA and GB124 phages over 80% of 364 
recorded log removal occurs in the initial stages of treatment (Treatment Stage 1), in which 365 
settling, screening, and activated sludge treatments take place. Somatic coliphage appear to 366 
be more resistant to Treatment Stage 1 with percentage log removal split fairly evenly 367 
between Treatment Stages 1 and 2. Adenovirus, which, perhaps unsurprisingly, was detected 368 
most often in MBR, demonstrated the largest percentage log removal during Treatment Stage 369 
3 (GAC and chlorination). These results suggest that although post-disinfection would be 370 
needed to achieve the higher removal requirement of existing reuse standards for drinking 371 
water (California Department of Public Health, 2014), MBR treatment could reduce the 372 
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chemical doses required to meet these standards in comparison to conventional treatment 373 
processes.   374 
 375 
4. Conclusions 376 
• This study, investigated for the first time the seasonal variability in the removal of 377 
viral pathogens, traditional indicators and potential phage surrogates in a full-scale 378 
MBR treatment system over a full twelve months, thus providing valuable new 379 
information on the potential risks to human health associated with the reuse of MBR 380 
effluents for the augmentation of potable water supplies. 381 
• In light of the findings of this study, it can be concluded that membrane bioreactor 382 
technology appears to have considerable potential to protect human health in 383 
wastewater reuse systems, potentially including the augmentation of potable water 384 
supplies. 385 
• However, the results of this study do not currently support the use of phages as 386 
surrogates for viral pathogens, because viral pathogen concentrations varied to a 387 
greater degree seasonally and were detected on a number of occasions on which 388 
phages were not detected (false negative sample results). 389 
• Future studies therefore need to ascertain the infectivity of viral particles to 390 
determine whether the presence of viral pathogens in chlorinated product during this 391 
study presents a real risk to human health.  392 
• Finally, the relatively low levels of suspended solids, organics and microbial 393 
contaminants observed in the MBR product of this study suggest that the previously 394 
perceived need for post-treatment disinfection (certainly prior to non-potable reuse) 395 
is not supported by the evidence of treatment efficacy. The work therefore supports 396 
the further development of reuse systems that are able to protect human health 397 
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without the need for chemical disinfection, thereby avoiding the production of 398 
potentially toxic disinfection by-products in recycled water. 399 
 400 
 401 
 402 
 403 
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Table 1. Correlation between phage indicators and pathogenic viruses 
a Two tailed significance, p<0.01 
 
 
 
 
 
 
 
 Somatic coliphages  FRNA phages GB124 phages  Adenovirus Norovirus GI 
FRNA 
phages 0.808
a
     
GB124 
Phages 0.829
a
 0.945a    
Adenovirus 0.675a 0.620a 0.619a   
Norovirus 
GI 0.646
a
 0.621a 0.604a 0.404a  
Norovirus 
GII 0.627
a
 0.590a 0.613a 0.614a 0.814a 
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Table 2. Physcio-chemical conditions at each treatment stage in the Old Ford WRP 
Parameter   Treatment Stage  N Minimum (mg/l) Mean (mg/l ) Maximum (mg/l) 
Biological   Raw sewage 37 79.6 210.5 355.9 
oxygen   Settled sewage 26 58.7 141.8 271.6 
demand  Screened sewage 29 46.2 133.3 262.1 
 Mixed Liquor 6 266.1 419.5 554.5 
 MBR product 37 <1.9 <1.9 <1.9 
 GAC product  29 <1.9 7.2 7.2 
  
 Reclaimed wastewater 185 <1.9 <1.9 <1.9 
Chemical  Raw sewage 37 198.0 699.0 5930.0 
oxygen  Settled sewage 30 154.0 329.3 401.0 
demand  Screened sewage 29 142.0 270.6 512.0 
 Mixed Liquor 74 644.0 175654.0 778000.0 
 MBR product 39 <1.9 15.9 22.8 
 GAC product  33 <1.9 13.9 22.3 
  
 Reclaimed wastewater 185 <1.9 15.0 48.3 
Suspended   Raw sewage 37 96.0 512.0 6720.0 
solids  Settled sewage 26 60.0 138.7 172.0 
 Screened sewage 29 47.5 94.3 240.0 
 Mixed Liquor 76 116 42363.0 433200.0 
 MBR product 37 <1.9 3.0 5.5 
 GAC product  29 <1.9 2.5 3.0 
 Reclaimed wastewater 189 <1.9 2.9 7.2 
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Figure 1. Sampling locations for four weekly monitoring of faecal indicator organisms 
(annotated 1-9) and viral pathogens (annotated a-d) at the Old Ford WRP. HRT = hydraulic 
retention time/h.  
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Figure 2. Mean log numbers of faecal thermotolerant coliforms and intestinal enterococci at 
each sampling location in the Old Ford WRP (cultured). Outliers (observations >1.5 times the 
interquartile range) are represented by a *. Boxes represent the interquartile range. (n=108). 
RW= raw sewage, Ase= after septic, Asc = after screening, An= after anoxic, ML= mixed 
liquor, RAS= returned activated sludge, MBR= membrane bioreactor product, GAC= 
granular activated carbon product, and CP = chlorinated product.  
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Figure 3. Mean log numbers of bacteriophages at each sampling location in the Old Ford 
WRP (cultured-based detection methods). Outliers (observations >1.5 times the interquartile 
range) are represented by a *. (n=108). Boxes represent the interquartile range. RW= raw 
sewage, Ase= after septic, Asc = after screening, An= after anoxic, ML= mixed liquor, RAS= 
returned activated sludge, MBR= membrane bioreactor product, GAC= granular activated 
carbon product, and CP = chlorinated product. 
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Figure 4. Confidence intervals (95%) for mean log numbers of select enteric viruses 
determined using qPCR. Individual standard deviations were used to calculate the intervals. 
(n=48) 
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Figure 5. Percentage log removal value (LRV) contributions from treatment stage 1 (septic, 
screening and anoxic), treatment stage 2 (mixed liquor to MBR) and treatment stage 3 (GAC 
and chlorination) of the Old Ford WRP for adenovirus (AdV), norovirus GI and GII (NoV), 
phages of GB124 (GB124), somatic coliphages (SC), and F-RNA phages (F-RNA). N= 48.  
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Highlights 
 
1. Seasonal variability of removal of viruses in a full-scale MBR is investigated. 
2. Log reductions of NoV GI/II and AdV of between 2.3 and 4.4 were achieved.  
3. AdV and NoV were both detected at low levels post chlorination in single samples. 
4. The findings do not support the use of phages as surrogates for viral pathogens. 
5. Future studies need to ascertain the infectivity of viral particles to determine risk. 
 
 
 
